Curis Lifesciences (NSE:CURIS) Beginning Cash Position: ₹4.18 Mil (As of Jun. 2024)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:CURIS Curis Lifesciences Ltd NSE:CURIS
23 GF Score
Price ₹200.05
! 3 Warning Signs
View Full Analysis

What is Curis Lifesciences Beginning Cash Position?

Curis Lifesciences NSE:CURIS -3.38% 23 Beginning Cash Position is ₹4.18 Mil as of Jun. 2024. GuruFocus rates NSE:CURIS with a GF Score™ of 23/100. The stock has 3 warning signs investors should review.

Curis Lifesciences's Beginning Cash Position for the quarter that ended in Jun. 2024 was ₹4.18 Mil.

Curis Lifesciences's quarterly Beginning Cash Position stayed the same from . 20 (₹0.00 Mil) to . 20 (₹0.00 Mil) but then increased from . 20 (₹0.00 Mil) to Jun. 2024 (₹4.18 Mil).

Curis Lifesciences's annual Beginning Cash Position increased from Mar. 2024 (₹1.52 Mil) to Mar. 2025 (₹4.18 Mil) but then declined from Mar. 2025 (₹4.18 Mil) to Mar. 2026 (₹3.04 Mil).

Curis Lifesciences Beginning Cash Position Related Terms

Curis Lifesciences Beginning Cash Position Historical Data

* Premium members only.

The historical data trend for Curis Lifesciences's Beginning Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Curis Lifesciences Beginning Cash Position Chart

Curis Lifesciences Annual Data
Trend Mar22 Mar23 Mar24 Mar25 Mar26
Beginning Cash Position
1.16 1.11 1.52 4.18 3.04

Curis Lifesciences Quarterly Data
Jun24
Beginning Cash Position 4.18
NSE:CURIS
23GF Score
Curis Lifesciences Ltd NSE:CURIS
Beginning Cash Position is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Curis Lifesciences Beginning Cash Position Calculation

Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement.

What does a Beginning Cash Position of ₹4.18 Mil mean?
Curis Lifesciences (NSE:CURIS) has a Beginning Cash Position of ₹4.18 Mil as of Jun. 2024. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Curis Lifesciences and its competitors.
Is Curis Lifesciences' Beginning Cash Position too high?
Curis Lifesciences' current Beginning Cash Position is ₹4.18 Mil. Overall, Curis Lifesciences has a GF Score™ of 23/100, reflecting its overall financial health beyond just this single metric.
How does Curis Lifesciences' Beginning Cash Position compare to ZTS?
Curis Lifesciences' Beginning Cash Position of ₹4.18 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beginning Cash Position for a Drug Manufacturers company?
A good Beginning Cash Position depends on the Drug Manufacturers industry context. However, Beginning Cash Position should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beginning Cash Position mean?
A high Beginning Cash Position can signal that a stock is expensive relative to its fundamentals. Beginning Cash Position is the cash and equivalents balance at the beginning of the accounting period, as indicated on the Cash Flow statement. View historical data on Curis Lifesciences and its competitors. Curis Lifesciences's current Beginning Cash Position is ₹4.18 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Curis Lifesciences stock overvalued right now?
Curis Lifesciences (NSE:CURIS) has a current Beginning Cash Position of ₹4.18 Mil. The current Beginning Cash Position is ₹4.18 Mil. Curis Lifesciences' overall GF Score™ is 23/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beginning Cash Position calculated?
Beginning Cash Position is calculated from a company's financial statements. For Curis Lifesciences (NSE:CURIS), the current Beginning Cash Position is ₹4.18 Mil as of Jun. 2024. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Curis Lifesciences Business Description

Address PF-23, GIDC Sanand - II, Industrial Acme Pharma, Opposite Teva Pharma, Sanand, Ahmedabad, GJ, IND, 382110
Curis Lifesciences Ltd is in the business of manufacturing of pharmaceutical products. It specializes in the manufacturing of a wide range of pharmaceutical products such as Tablets, Capsules, External Preparations, Oral liquid, and Sterile Ophthalmic Ointments. The company's business verticals are: Loan License manufacturing, Contract Manufacturing, and Direct Export. The company derives revenue from the sale of its pharmaceutical products.
23GF Score

Get the complete analysis for NSE:CURIS

Beginning Cash Position is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹200.05
Price